Human apurinic/apyrimidinic endonuclease is a novel drug target in cancer

QR Code

Human apurinic/apyrimidinic endonuclease is a novel drug target in cancer

Bibliographic Details
Main Authors:	Abbotts, Rachel, Perry, Christina, Madhusudan, Srinivasan
Other Authors:	Vengrova, Sonya
Format:	Book Section
Published:	InTech 2011
Online Access:	https://eprints.nottingham.ac.uk/3182/

Similar Items

Pre-clinical development of human apurinic/apyrimidinic endonuclease (APE1) inhibitors for cancer therapy
by: Mohammed, Mohammed Zubair Khuder
Published: (2011)

DNA repair in cancer: emerging targets for personalized therapy
by: Abbotts, Rachel, et al.
Published: (2014)

Restriction endonuclease analysis of local Brucella isolates
by: Maureen, J., et al.
Published: (2004)

Comparison of herpesvirus isolates from falcons, pigeons and psittacines by restriction endonuclease analysis
by: Aini, I., et al.
Published: (1993)

Targeting DNA repair for personalisation of glioblastoma therapy
by: Perry, Christina Joy
Published: (2016)

Untwisting of the DNA helix stimulates the endonuclease activity of Bacillus subtilis Nth at AP sites
by: Collier, Christopher, et al.
Published: (2011)

Genetic analysis of two structure-specific endonucleases Hef and Fen1 in archaeon Haloferax volcanii
by: Duan, Zhenhong
Published: (2009)

Isolation and restriction endonuclease (RE) site characterization of human 20-KDA myosin light chain 2 (MLC-2) gene from human colorectal system
by: Chia, Christine Pek Imm
Published: (2007)

From microbial gene essentiality to novel antimicrobial drug targets
by: Mobegi, Fredrick, et al.
Published: (2014)

Class II Phosphoinositide 3-Kinases as Novel Drug Targets
by: Falasca, Marco, et al.
Published: (2017)

A side-effect free method for identifying cancer drug targets
by: Ashraf, Md. Izhar, et al.
Published: (2018)

A review on current nanomaterials and their drug conjugate for targeted breast cancer treatment
by: Jinling, Joanna Lee, et al.
Published: (2017)

Targets and mechanisms of berberine,a natural drug with potential to treat cancer with special focus on breast cancer
by: Kaboli, Parham Jabbarzadeh, et al.
Published: (2014)

Development of multifunctional drug delivery systems based on virus-like nanoparticles for cancer targeting drug delivery
by: Biabanikhankahdani, Roya
Published: (2017)

Bone drug targets
by: Dass, Crispin
Published: (2018)

NHE-1: A promising target for novel anti-cancer therapeutics
by: Loo, S., et al.
Published: (2012)

Ataxia telangiectasia mutated and Rad3 related (ATR) protein kinase inhibition is synthetically lethal in XRCC1 deficient ovarian cancer cells
by: Sultana, Rebeka, et al.
Published: (2013)

Are DNA repair factors promising biomarkers for personalized therapy in gastric cancer?
by: Abdel-Fatah, Tarek, et al.
Published: (2013)

COX-2 inhibitors: a potential target for drug therapy in the management of colorectal cancer
by: Ryan, A R, et al.
Published: (1999)

Colorectal cancer stem cells: a review of targeted drug delivery by gold nanoparticles
by: Mohd Zahid, Manali Haniti, et al.
Published: (2020)

In silico design and evaluation of novel cell targeting melittin-interleukin-24 fusion protein: a potential drug candidate against breast cancer
by: Rehman, Hafiz Muhammad, et al.
Published: (2023)

Targeting inflammation in non-small cell lung cancer through drug repurposing
by: Rajasegaran, Thiviyadarshini, et al.
Published: (2023)

ADAM19: A Novel Target for Metabolic Syndrome in Humans and Mice
by: Weerasekera, L., et al.
Published: (2017)

Editorial: Current drug targets
by: Sulaiman, Ahmad Hatim, et al.
Published: (2019)

Novel functionalized polymers for nanoparticle formulations with anti cancer drugs
by: Puri, Sanyogitta
Published: (2007)

Exploring gene editing using site-specific endonucleases as an approach to improve in vitro models of TNF Receptor-Associated Periodic Syndrome (TRAPS)
by: Alotiby, Amna
Published: (2017)

Targeting ataxia telangiectasia mutated and Rad3 related kinase (ATR) in PTEN deficient breast cancers for personalized therapy
by: Al-Subhi, Nouf, et al.
Published: (2018)

Molecular Cloning, Expression, And Characterization Of Glutathione-Stransferase As A Novel Target In Antimalarial Drug Design And Discovery
by: Al-Qattan, Mohammed Nooraldeen Mahmod
Published: (2015)

The Synthesis and Evaluation of Novel Core-Shell Nanostructured Metal Oxides for Cancer Targeting
by: Patel, Kunal Kamleshkumar
Published: (2016)

Polyadenylation as a target for anti-inflammatory drugs
by: Radhi, Masar
Published: (2019)

Identification of drug(s) selectively targeting colorectal cancer stem-like cells for differentiation (differentiation therapy)
by: Ahmed, Mehreen
Published: (2020)

Drug-targetting of duplex and quadruplex DNA
by: Gavathiotis, Evripidis
Published: (2002)

Kinase targets in CNS drug discovery
by: Gunosewoyo, Hendra, et al.
Published: (2017)

System-level analysis of neuroblastoma tumor-initiating cells implicates AURKB as a novel drug target for neuroblastoma
by: Morozova, O., et al.
Published: (2010)

In-silico drug target design & its approaches
by: Abduallah Alsafi, Hassen Mohammed, et al.
Published: (2011)

Macromolecules as targeted drugs delivery vehicles: an overview
by: Ali, Yousaf, et al.
Published: (2019)

The therapeutic and psychosocial interaction in enhancing drug targets
by: Musa, Ramli, et al.
Published: (2018)

NMR Studies of Nucleic Acids as Drug Targets
by: Gallagher, Cathal T
Published: (2004)

Targeted bio-distribution of drugs to the lymphatic system
by: Jewell, Adelaide
Published: (2022)

Development of Helicobacter pylori BabA minimal binding domain as a novel biomimetic moiety for gastric-targeted drug delivery
by: Mohammed, Aymen
Published: (2020)